Tradewinds Capital Management, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tradewinds Capital Management, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$10,000
-47.4%
1370.0%0.00%
-62.5%
Q3 2019$19,000
-24.0%
1370.0%0.01%
-20.0%
Q2 2019$25,000
+13.6%
1370.0%0.01%
+25.0%
Q1 2019$22,000
+69.2%
1370.0%0.01%
+33.3%
Q4 2018$13,000
-31.6%
1370.0%0.01%
-14.3%
Q3 2018$19,000
-9.5%
1370.0%0.01%
-22.2%
Q2 2018$21,000
-4.5%
1370.0%0.01%
-10.0%
Q1 2018$22,000
-4.3%
1370.0%0.01%
-9.1%
Q4 2017$23,000
+155.6%
1370.0%0.01%
+120.0%
Q3 2017$9,000
-18.2%
1370.0%0.01%
-16.7%
Q2 2017$11,000
+10.0%
1370.0%0.01%0.0%
Q1 2017$10,0001370.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders